ANRO

Alto Neuroscience, Inc.

NYSE · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Alto Neuroscience is a clinical-stage pharmaceutical company developing treatments for psychiatric disorders such as depression, PTSD, and schizophrenia. It uses biomarkers, including EEG and other physiological data, to match patients with specific drug candidates based on their individual brain function profiles.

Industry

Pharmaceutical Preparations

Headquarters

Mountain View, CA

Exchange

NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
Smith Nicholas ConradPRESIDENT AND CFO	Sell	$2.95M	110,830at $26.58	Sep 29, 2026
Smith Nicholas ConradPRESIDENT AND CFO	Sell	$597K	23,170at $25.78	Sep 30, 2026
Smith Nicholas ConradPRESIDENT AND CFO	Sell	$24K	886at $26.87	Sep 30, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ANRO.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ANRO activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

Mobile number (optional)

Leave mobile blank for email only. Outside US/Canada, include + and your country code.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.